RxDoctor Payments DataLook up a doctor →

RYLAZE: payments to doctors

Payments that named RYLAZE as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$3.2M
Providers
1,925
Transactions
6,105
Average per transaction
$522

The per-transaction average — $522 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 1,925 providers the average total is $1,656, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
JAZZ Pharmaceuticals Inc.$3,134,49698.3%
Jazz Pharmaceuticals Inc.$53,6711.7%
← All drugs & devices